These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

277 related items for PubMed ID: 17594742

  • 21. [PSA based screening for prostatic cancer].
    Johansen TE.
    Tidsskr Nor Laegeforen; 2008 Nov 20; 128(22):2612-4. PubMed ID: 19023357
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Prostatic volume and volume-adjusted prostate-specific antigen as predictive parameters for T1c prostate cancer.
    Tanaka N, Fujimoto K, Yoshikawa M, Tanaka M, Hirao Y, Kondo H, Saito I.
    Hinyokika Kiyo; 2007 Jul 20; 53(7):459-65. PubMed ID: 17702178
    [Abstract] [Full Text] [Related]

  • 24. [Detection of prostate cancer: yes or no?].
    Van Cangh PJ.
    Bull Mem Acad R Med Belg; 2006 Jul 20; 161(3-4):159-69. PubMed ID: 17172224
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Screening for prostate cancer in 2007: the PSA era and its challenges are not over.
    Shariat SF, Karakiewicz PI.
    Eur Urol; 2008 Mar 20; 53(3):457-60. PubMed ID: 18079050
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Is an improved PSA screening test in sight?
    Savage L.
    J Natl Cancer Inst; 2007 Oct 17; 99(20):1503-4. PubMed ID: 17925529
    [No Abstract] [Full Text] [Related]

  • 36. [The National Board of Health and Welfare's guidelines for prostatic cancer care. PSA test screening--only for well-informed men].
    Bratt O, Damber JE, Kärvinge C, Malm T, Hensjö LO, Hyttsten E.
    Lakartidningen; 2007 Oct 17; 105(8):524-8. PubMed ID: 18363292
    [No Abstract] [Full Text] [Related]

  • 37. [PSA test inconvenience?].
    Drøsdal HH.
    Tidsskr Nor Laegeforen; 2005 Mar 03; 125(5):623; author reply 623. PubMed ID: 15776048
    [No Abstract] [Full Text] [Related]

  • 38. What can be concluded from the ERSPC and PLCO trial data?
    Studer UE, Collette L.
    Urol Oncol; 2010 Mar 03; 28(6):668-9. PubMed ID: 21062648
    [Abstract] [Full Text] [Related]

  • 39. Long-term prediction of prostate cancer: prostate-specific antigen (PSA) velocity is predictive but does not improve the predictive accuracy of a single PSA measurement 15 years or more before cancer diagnosis in a large, representative, unscreened population.
    Ulmert D, Serio AM, O'Brien MF, Becker C, Eastham JA, Scardino PT, Björk T, Berglund G, Vickers AJ, Lilja H.
    J Clin Oncol; 2008 Feb 20; 26(6):835-41. PubMed ID: 18281654
    [Abstract] [Full Text] [Related]

  • 40. [PSA test--one more time].
    Drøsdal HH.
    Tidsskr Nor Laegeforen; 2005 May 19; 125(10):1384; author reply 1384. PubMed ID: 15909026
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.